BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8268837)

  • 1. Phenotypic and functional changes in chronic lymphocytic leukemia.
    Răileanu-Moţoiu I; Dumitrescu A
    Rom J Intern Med; 1993; 31(2):99-108. PubMed ID: 8268837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
    Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
    Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between the capacity to be stimulated of lymphocyte subpopulations and the RAI staging in patients with chronic lymphocytic leukemia].
    Heilmann E; Venne U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):365-74. PubMed ID: 89987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional properties of B-lymphocytes of patients with a B-cell variant of chronic lymphocytic leukemia and chronic glomerulonephritis].
    Ostanin AA; Chernykh ER; Shubinskiĭ GZ; Nekipelova VI; Tov NL; Lozovoĭ VP
    Vestn Akad Med Nauk SSSR; 1991; (12):19-23. PubMed ID: 1801468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
    Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
    Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The heterogeneity of the immunological phenotype and of the proliferative characteristics of the lymphoid cells in chronic B-cell lympholeukemia].
    Kariagin IE; Tsveĭbakh AS; Afanas'ev BV
    Vopr Onkol; 1992; 38(6):667-74. PubMed ID: 1300767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interindividual phenotypic variations in CLL B lymphocyte maturation indication of different maturation blocks.
    Rozynkowa D; Antosz H; Rupniewska ZM; Kurowska M; Kulig A; Welcz B; Gorski G; Wojcierowski J
    Acta Anthropogenet; 1985; 9(1-3):48-62. PubMed ID: 3939670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
    Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
    Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absence of correlation between immunoregulatory T cells and induced lymphoproliferative response in treated B-chronic lymphocytic leukemia patients.
    Milosević D; Marinković M; Colović M; Jelić S
    Panminerva Med; 1999 Jun; 41(2):93-7. PubMed ID: 10479904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered function and membrane properties of lymphocytic leukemia cells. Correlation with clinical stage of disease.
    Prokocimer M; Polliack A; Rosenkovitch E; Ben-Bassat H
    Isr J Med Sci; 1982 Jul; 18(7):746-52. PubMed ID: 7107217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
    Eisele L; Haddad T; Sellmann L; Dührsen U; Dürig J
    Leuk Res; 2009 Jun; 33(6):775-8. PubMed ID: 18922578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface markers of lymphocytes and immunoglobulin alterations in chronic lymphocytic leukemia (CLL).
    Aydar S; Oğüt A; Undük H; Gündüz M
    New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):152-60. PubMed ID: 16302701
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic lymphocytic leukemia. II. Differentiation of various forms of chronic lymphocytic leukemia by cytological and immunological indicators].
    Popova L; Apostolov P; Vlaĭkova S; Stamenova L
    Vutr Boles; 1988; 27(3):76-80. PubMed ID: 3264645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
    Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of T lymphocytes by protein A from Staphylococcus aureus in B-derived chronic lymphocytic leukaemia.
    Guglielmi P; Preud'Homme JL
    Clin Exp Immunol; 1980 Jul; 41(1):136-40. PubMed ID: 6969148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.